HPS6 and cancer: As an encapsulated chemo drug in the self-assembled TPP-PEG-biotin NDDSs, the Ru-1 complex was selected because it showed an excellent anticancer activity against drug resistant cancer cells (MCF-7 and HCT-116) and targeted GRP78 successfully.